Vital Transformation understands the implications of new medical procedures, technologies and policies. We measure their impact on current clinical practices in close collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.
OUR RESEARCH
Everybody Loses with Most Favored Nation Reference Pricing. . .Except China.
Key takeaways
If MFN were adopted in Medicare and Medicaid, based upon our preliminary estimate it could lead to 1.3 million fewer jobs over ten years.
$2.8 trillion in lost earnings over 10 years due to MFN being applied to Medicare, resulting in $700 billion in reduced tax revenue.
By undermining the U.S. economic environment, MFN risks accelerating the movement of U.S. biopharma research and development to China.
Our clients include many of the world’s leading health care organisations.
